OPT
Opthea Limited Sponsored ADR · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website opthea.com
- Employees(FY) 24
- ISIN US68386J2087
Performance
-1.5%
1W
-17.75%
1M
+11.52%
3M
+91.27%
6M
+11.52%
YTD
-13.99%
1Y
Profile
Opthea Limited, a clinical stage biopharmaceutical company, engages in the development and commercialization of therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead product candidate is Sozinibercept (OPT 302), a soluble form of vascular endothelial growth factor receptor-3 VEGFR-3, currently under Phase 3 clinical development as a novel therapy for wet age-related macular degeneration and diabetic macular edema. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.
Technical Analysis of OPT 2024-05-03
Overview:
In analyzing the technical indicators for OPT stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions to guide invest...
Recent News & Updates
- 2024-04-30 19:30
- 2024-04-24 21:00
- 2024-04-08 06:42
Opthea Appoints John Han, PharmD, as VP Medical Affairs(Globenewswire)
- 2024-04-04 06:34
- 2024-04-03 05:39
Opthea Appoints Sujal Shah to the Board of Directors(Globenewswire)
- 2024-03-23 19:55
11 Best ASX Stocks To Buy Now(Insidermonkey)
- 2024-03-18 18:00
- 2024-03-05 04:08
- 2024-02-28 04:55
- 2024-02-19 05:25
- 2024-02-13 18:00
- 2024-02-04 14:11
10 Best Australian Stocks To Buy(Yahoo Finance)
- 2024-01-31 17:00
- 2023-12-26 17:00
- 2023-12-18 17:00
Opthea Receives A$8.8 million R&D Tax Incentive(Globenewswire)
- 2023-11-30 16:30
Opthea to Present at the FLORetina 2023 Congress(Globenewswire)
- 2023-11-08 16:30
- 2023-10-29 17:30
- 2023-10-26 17:30
- 2023-10-01 17:30
Opthea to Participate at the 2023 Euretina Congress(Globenewswire)
- 2023-09-06 17:30
- 2023-08-27 17:30
- 2023-07-25 18:00
- 2023-07-23 18:00
- 2023-07-12 18:00
- 2023-07-09 18:00
- 2023-06-07 18:00
- 2023-05-24 20:00
- 2023-05-24 18:00
- 2023-05-16 18:00
Page 1 of 3
previousnext